[What is ascertained in the therapy of axial spondyloarthritis?].

about

[What is ascertained in the therapy of axial spondyloarthritis?].

Item

http://www.wikidata.org/entity/Q46057173

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[What is ascertained in the therapy of axial spondyloarthritis?].

@en

[What is ascertained in the therapy of axial spondyloarthritis?].

@nl

type

Item

label

[What is ascertained in the therapy of axial spondyloarthritis?].

@en

[What is ascertained in the therapy of axial spondyloarthritis?].

@nl

prefLabel

[What is ascertained in the therapy of axial spondyloarthritis?].

@en

[What is ascertained in the therapy of axial spondyloarthritis?].

@nl

P1476

[What is ascertained in the therapy of axial spondyloarthritis?].

@en

P2093

F Heldmann

http://www.w3.org/2001/XMLSchema#string

J Braun

http://www.w3.org/2001/XMLSchema#string

U Kiltz

http://www.w3.org/2001/XMLSchema#string

X Baraliakos

http://www.w3.org/2001/XMLSchema#string

P2860

Q24816951

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial.

The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.

P304

1450-1458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00108-013-3331-7

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24281787

http://www.w3.org/2001/XMLSchema#string